Atlas Trials

A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome

Clinical trial NCT03936777 · COMPLETED

Trial details

NCT number
NCT03936777
Sponsor
Zogenix, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dravet SyndromeLennox Gastaut SyndromeEpileptic Encephalopathy
Start date
2019-04-22
Primary completion
2025-05-08
Enrollment
412

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.